glp-1 vs tirzepatide difference Beyond glycemia: Comparing to analogues Understanding GLP-1 vs. GIP Medications:

Our nurse practitioners work with you to develop a plan that aligns with your daily routine, such as: Flexible appointment scheduling to accommodate work commitments

Compliant with the NZ Therapeutic Products Act 2023. Consumer Guarantees Act 1993 and Fair Trading Act 1986 apply

Excess body weight is a risk factor for both diabetes and cardiovascular disease (CVD)

With obesity linked to serious conditions such as heart disease, high blood pressure, and diabetes, Ozempic offers a powerful tool to help patients regain control of their health

This offers several potential benefits: Avoids first-pass metabolism : Unlike swallowed medications that must pass through the liver, sublingual absorption delivers drugs directly to the bloodstream Bypasses stomach acid : GLP-1 peptides are degraded by digestive enzymes, so avoiding the stomach could improve stability Rich vascular network : The area under the tongue has extensive blood vessels that allow rapid absorption However, research on peptide delivery through oral mucosa reveals significant challenges: Peptides like semaglutide and tirzepatide have molecular weights around 4000 Da (compounds above 500 Da generally show poor permeability) Salivary and mucosal proteases degrade peptides before they can cross the epithelial barrier Continuous saliva production dilutes and washes away the medication Studies with insulin showed only 1-2% bioavailability via buccal/sublingual routes without absorption enhancers The key question: Do compounded ODT formulations overcome these barriers